Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.

A retrospective assessment of patient records identified common oral complications of radiotherapy and chemoradiotherapy for head and neck cancers.

Topline data were announced from a phase 3 trial evaluating zanzalintinib in combination with atezolizumab in patients with previously treated non-microsatellite instability (MSI)-high metastatic ...

Our trial provides proof of concept that cytokine-armored CAR T-cell treatment is feasible and may enhance antitumor activity without additional toxic effects,” researchers reported.

The survey was conducted in May 2025 online (978 participants) and by telephone (30 participants).

A review of the literature revealed that immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse effect of CAR-T therapy.

Tobacco use is a modifiable risk factor attributed to an increased risk for many cancers, including esophageal cancer. What ...

In patients with multiple myeloma (MM), serum concentration of chitinase 3-like protein-1 (CHI3L1) protein is correlated with disease severity and predicts disease progression, according to research ...

Relacorilant plus nab-paclitaxel could be a new standard of care for platinum-resistant ovarian cancer, according to Alexander Olawaiye, MD.

Launch prices for self-administered targeted anticancer therapies have grown precipitously,” researchers wrote.

After transformation, survival rates varied by original cancer type, with the poorest prognosis for those transformed from CLL/SLL and from LPL/WM.

HealthDay News — Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study published online July 21 in ...